Understanding the Common Side Effects of Wegovy

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling fullness to your brain—mechanisms that produce rapid weight loss but also trigger temporary digestive adjustments. Most patients experience mild to moderate side effects in the first 2–4 weeks that fade as the body adapts. Knowing which reactions are normal and how to manage them increases treatment success.

Why Semaglutide Causes Nausea and Digestive Changes

Semaglutide activates GLP-1 receptors throughout your digestive tract, slowing the rate at which your stomach moves food into the small intestine. This delay is the primary driver of reduced appetite and steady weight loss, but it also creates a sensation of fullness earlier in meals and can trigger nausea, especially after eating larger portions or fatty foods. Your gut bacteria and digestive enzymes also need time to recalibrate to smaller food volumes.

The nausea typically peaks within the first 1–2 weeks after starting semaglutide or increasing your dose, then gradually subsides as your gastrointestinal system adapts. Research shows that 25–30% of patients report mild nausea, while severe nausea affecting daily function occurs in fewer than 5% of cases. Staying hydrated, eating smaller meals, and avoiding rich or greasy foods during the adjustment period significantly reduces this symptom.

Constipation, Appetite Loss, and Other Common Reactions

Constipation ranks among the most frequent side effects because slower stomach emptying and reduced food intake both decrease the volume of stool moving through your colon. Increasing water intake to at least 80 ounces daily, adding fiber-rich vegetables, and moving your body regularly (even 10-minute walks after meals) resolve constipation in most patients within 2–3 weeks. Over-the-counter stool softeners are safe to use alongside semaglutide if needed.

Some patients also experience vomiting, mild diarrhea, headaches, or fatigue during the first two weeks—all reflections of your body adjusting to hormonal signals telling it to eat less. These reactions are temporary and unrelated to the medication's safety. Taking your semaglutide injection at the same time each week, eating protein-rich foods at each meal, and allowing 48 hours between injections and intense exercise can help manage these adjustment symptoms.

How Dose Adjustments Reduce Side Effects Without Raising Cost

PlexusDx compounds semaglutide at a flat monthly rate of $189, regardless of your starting dose or whether your dose increases over time. Most treatment plans begin at lower doses (0.25 mg weekly) to allow your body to adapt, then gradually increase every 4 weeks until you reach an effective dose. Slow titration reduces nausea and digestive upset while maintaining consistent monthly affordability.

Your dose may need to go up as your body adapts or your weight loss goal changes—but your price won't. This pricing structure removes the financial barrier that sometimes causes patients to skip dose increases or stop treatment prematurely when side effects feel strongest. PlexusDx clinical coordinators also adjust your regimen based on how you respond, helping you find the dose that balances efficacy with tolerability.

How Your Genetics Relate to GLP-1 Pathways

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437) and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with genetic profiles showing lower GLP1R receptor sensitivity may benefit from slightly higher doses or combination therapy (like PlexusDx's GLP-Squared Injection), while those with high receptor sensitivity often do better with slower titration and careful monitoring. This precision approach turns side effect management from guesswork into data-driven strategy, improving both outcomes and patient satisfaction.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How long do semaglutide side effects typically last?

Most nausea, constipation, and appetite-suppression side effects peak in the first 1–2 weeks after a dose increase and resolve within 2–4 weeks as your body adapts. Staying hydrated, eating smaller frequent meals, and avoiding fatty foods speeds this adjustment. If side effects persist beyond 4 weeks, contact your PlexusDx care coordinator to discuss dose timing or alternative formulations.

Is nausea from semaglutide dangerous, and when should I worry?

Mild nausea is a normal and expected side effect that does not indicate danger. However, severe vomiting that prevents you from keeping down food or liquids for more than a few hours requires immediate medical attention to rule out other conditions. Most patients manage mild nausea with ginger tea, smaller portions, and time—no medication change needed.

Why does PlexusDx charge a flat monthly price even when my dose goes up?

PlexusDx pricing ($189/month for semaglutide injection across all dose levels) ensures cost predictability and removes financial obstacles to safe dose escalation. Your dose may need to go up—your price won't. This model encourages patients to work with their care team on optimizing dosing for safety and results, not avoiding increases due to cost.

Can I reduce side effects by switching between injection and oral semaglutide?

Oral semaglutide ($289/month) generally produces fewer gastrointestinal side effects than injections because it bypasses rapid absorption into the bloodstream, though it also takes longer to reach peak effectiveness. Some patients find oral formulations easier to tolerate during the adjustment phase. PlexusDx can discuss switching between injection and oral semaglutide based on your side effect experience and treatment goals.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy Side Effects
• Mounjaro Side Effects Plexusdx
• Glp 1 Side Effects Plexusdx
• Tirzepatide Vs Semaglutide Side Effects

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.